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Abstract
We incorporate basic genetics into an AIDS model. We illustrate that if a homozygote is immune to the
disease or is resistant to the effects of the disease, the corresponding allele goes to fixation. On the other
hand, if the heterozygote is immune to the disease or is resistant to the effects of the disease, polymorphism
usually occurs.
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1. Introduction
Early models of AIDS progression in the United States focused on homosexual populations
for which reproduction is not relevant. However, the devastating impact of AIDS becomes in-
creasingly evident, especially in developing nations, when both sexes are severely affected by
HIV infection and AIDS. See the annual UNAIDS/WHO report, AIDS epidemic, Special Report
on HIV Prevention, [28], that documents the impact of HIV infection and AIDS for specific data
regarding infection rates, methods of infection, and comparisons of the virus impact on countries
and continents.
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the case of sickle-cell disease, HbS carriers (of genotype HbB/HbS) are protected from malaria
infection while HbS homozygotes are faced with sickle-cell anemia and HbB homozygotes have
less resistance to malaria, Ashley-Koch et al., [2].
Many scientists now believe that carriers of the CCR5 mutation, 32, appear to be immune
to the bacteria (Yersinia pestis) that causes plague, as well as the virus (HIV) that causes AIDS,
which gives hope in finding new treatments for both of those diseases, Smith et al., [24]. Inter-
estingly, in areas of Europe and America that were affected by the 1665 plague, about 14% of
the population is a CCR532 carrier while in areas unaffected by the plague virtually 0% are
carriers, Stephens et al., [27], or Mystery of the Black Death, [20]. Hayes et al., [12], report an
allelic frequency of the CCR532 polymorphism to be 0.092 in Caucasians and to be rare in
African populations, ranging from 0 for Xhosa (of central African descent) to 0.03 for a popula-
tion with mixed ancestral descent. Rodés et al., [23], indicate that 1–5% of individuals infected
with HIV-1 have shown no signs of development of AIDS after 16 years of study. Mulherin
et al.’s studies, [16], indicate that CCR532 and CCR264I carries progress from HIV infection
to the development of AIDS at a rate that is 25 percent slower than those without these mutations;
the mutation carriers’ progression from the development of AIDS to death appears to be 25–35
percent less as well. For Eurasia, Stephens et al., [27], have shown a decline of 0% to 14% of
the CCR532 polymorphism and that it is absent in (most) African, American Indian, and East
Asian ethnic groups. The CCR2 mutation occurs in 20–25 percent of Americans and appears to
delay the onset of AIDS for two to three years in people who are HIV positive, [22]. The same
report also indicates that the 40 percent of HIV carriers who progress rapidly from HIV infection
to the development of AIDS do so because of their individual genetics.
In this paper, we form a model of how a population consisting of two groups, a category sus-
ceptible to a disease and a category infected by a disease that is spread by individual–individual
contact after it is introduced into a population (like AIDS), might evolve if one genotype is im-
mune to the disease or more resistant to the disease than other genotypes (as CCR532 carriers
are to the plague). See Hethcote, [13], for an overview of the mathematics of the standard SIR
epidemic and endemic models as well as many other classic epidemic and endemic models.
Of course, the progression from infection with HIV to the development of AIDS is compli-
cated and almost certainly involves numerous genetic factors such as epistasis, Martin et al.,
[15], who examine the epistatic interaction between KIR3DS1 and HLA-B, Wills et al., [30],
and Bream et al., [8], that are not considered here. We hope to combine the model developed
here with the epistasis model developed in Braselton et al., [7], to model the epistasis interaction
observed by Martin et al., [15], in a later study.
To do so, we incorporate basic genetics into a standard AIDS model by dividing the population
under consideration into three genotypes of type AA, Aa, and aa, the usual classification of
a one locus two allele problem. We show that if one homozygote has an advantage over the
other genotypes then the advantaged allele typically goes to fixation. If the heterozygote has an
advantage over the others, polymorphism generally occurs. However, even without heterozygous
advantage, polymorphism may occur, Zhang and Jiang, [31].
The development of a vaccine against HIV has been difficult. We also see that the progression
from HIV infection to the development of AIDS depends on many factors. A very small percent-
age of the population appears to be immune to infection of HIV, in spite of repeated exposure
to HIV. Once infected by HIV, a particular individual’s progression to the development of AIDS
appears to depend on many factors, including the particular strain of HIV as well as the genetics
of the individual. For example, some strains of HIV are more resistant to drugs than other strains
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infected by other strains of HIV. The National Institutes for Health, [22], reports that the approxi-
mately 40 percent of HIV positive patients who progress from HIV infection to AIDS quickly do
so to genetics. In addition to the (small) percentage of the population that appears to be immune
to contracting HIV, another percentage of the population appears to be immune to developing
AIDS even though they are HIV positive. No one knows if these long-term HIV carriers will
ever develop AIDS, yet the fact that they exhibit no signs of developing AIDS as well as possess
the ability to transmit HIV to other individuals is of interest.
For many virally transmitted diseases, compartmental category models include a “recovered”
group. For the AIDS model, however, a “recovered” group is not considered because there is no
vaccine against HIV and there are no (well-agreed upon) documented cases of elimination of
HIV from an individual infected with HIV.
2. Background
Suppose that the population of males has size N(t), X(t) represents the size of the population
that is susceptible, Y(t) the infected males, A(t) the number of AIDS patients, and Z(t) the
size of the population infected with HIV that does not develop AIDS. With the assumption that
the population grows at constant rate B , the basic model of an AIDS epidemic in a homosexual
population (Murray, [21]) takes the form
dX
dt
= B − μX − ω Y
N
X,
dY
dt
= ωX
N
Y − (v + μ)Y,
dA
dt
= pvY − (σ + μ)A,
dZ
dt
= (1 − p)vY − μZ,
N(t) = X(t) + Y(t) + Z(t) + A(t), (1)
where σ represents the AIDS related death rate, μ the natural death rate, ω a constant that de-
pends on the number of sexual partners as well as the probability of acquiring infection, v the
rate at which infection leads to AIDS, and p the fraction of the infected population that develops
AIDS.
The immune population is a reservoir host, which most would believe increase the incidence
of the disease because the immune population suffers no negative effects of infection; it serves
as a “free” mode of transmission to the virus. In this paper, we show that in some situations,
a reservoir host can reduce the impact of the disease on the non-immune individuals.
For a non-homosexual population, Baryarama et al., [3], study a generalization of system (1)
for which the susceptible population excludes the number of AIDS cases from the population,
N(t) = X(t)+Y(t) represents the size of the population that can transmit HIV, but does not take
into account the size of the population infected with HIV that does not develop AIDS:
dX
dt
= αN − μX − ω Y
N
X,
dY = ωXY − (v + μ)Y,
dt N
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dt
= vY − (σ + μ)A,
N(t) = X(t) + Y(t), (2)
where ω = ω(t), v = v(t), and σ = σ(t) have the same meanings as in system (3) but are vari-
able.
The size of the population infected with HIV that does not develop AIDS is important so
combining systems (1) and (3) results in
dX
dt
= αN − μX − ω Y
N
X,
dY
dt
= ωX
N
Y − (v + μ)Y,
dA
dt
= pvY − (σ + μ)A,
dZ
dt
= (1 − p)vY − μZ,
N(t) = X(t) + Y(t) + Z(t). (3)
In the absence of AIDS, Y = A = Z = 0, system (3) reduces to the exponential growth model,
X′ = (α − μ)X.
2.1. Logistic growth of the population in the absence of AIDS
Although logistic growth is more complicated, we prefer the logistic equation, X′ = αX −
μX2, because it allows us to examine specific population densities rather than ratios as with the
exponential models. Incorporating logistic (limited) growth into system (3) results in
dX
dt
= αN − μX2 − ω Y
N
X,
dY
dt
= ωX
N
Y − (v + μ)Y,
dA
dt
= pvY − (σ + μ)A,
dZ
dt
= (1 − p)vY − μZ,
N(t) = X(t) + Y(t) + Z(t). (4)
In the absence of AIDS, the population grows logistically: limt→∞ X(t) = α/μ. Note that sys-
tem (4) is quite similar to the system studied by Elbasha and Gumel, [10], who incorporate an
imperfect vaccine into an AIDS model. In our case, we do not assume that the X population
grows at a constant rate. Further, we assume that a certain percentage of the HIV infected popu-
lation is immune to developing AIDS, rather Elbasha and Gumel assume that the percentage of
the vaccinated population is immune to contracting HIV but a certain percentage is not (because
the vaccine is imperfect).
System (4) has equilibrium solutions E0 = (α/μ,0,0,0) and E∗ = (X∗, Y∗,A∗,Z∗), where
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2
((p − 1)v − μ)μ(v + μ)
= v + μ
v + μ − pv +
μ(α − μ) + v((1 − p)α − μ)
(v + μ − pv)μ(v + μ) ω,
Y∗ = μ(v + μ − ω)
((p − 1)v − μ)(v + μ)X∗
= − (v + μ − ω)(μ(v + μ)
2 − (μ(μ − α) + v((p − 1)α + μ))ω)
(v + μ)2(−pv + v + μ)2 ,
A∗ = pvμ(v + μ − ω)
((p − 1)v − μ)(v + μ)(μ + σ)X∗
= pv(v + μ − ω)((μ(μ − α) + v((p − 1)α + μ))ω − μ(v + μ)
2)
(v + μ)2(−pv + v + μ)2(μ + σ) ,
and
Z∗ = (1 − p)v(v + μ − ω)
((p − 1)v − μ)(v + μ)X∗
= (1 − p)v(v + μ − ω)((μ(μ − α) + v((p − 1)α + μ))ω − μ(v + μ)
2)
μ(v + μ)2(−pv + v + μ)2 .
Evaluated at E0, the Jacobian of system (4),
J(E0) =
⎛
⎜⎝
−α α − ω 0 α
0 −v − μ + ω 0 0
0 pv −μ − σ 0
0 v − pv 0 −μ
⎞
⎟⎠ ,
has eigenvalues λ1 = −α, λ2 = −μ, λ3 = −μ − σ , and λ4 = ω − (v + μ). Thus, E0 is unstable
if ω > v + μ and stable if ω < v + μ. If X∗ exists and ω > v + μ, E∗ exists.
Evaluated at E∗, the Jacobian of system (4),
J(E∗)
=
⎛
⎜⎜⎜⎜⎜⎜⎝
J1,1
μ(v+μ)2−((p−1)v(v−α)+((p−1)v+α)μ)ω
((p−1)v−μ)ω 0
μ(v+μ)2−(μ(α+μ)+v(−pα+α+μ))ω
((p−1)v−μ)ω
− μ(v+μ−ω)2
((p−1)v−μ)ω −μ(v+μ)(v+μ−ω)((p−1)v−μ)ω 0 −μ(v+μ)(v+μ−ω)((p−1)v−μ)ω
0 pv −μ − σ 0
0 v − pv 0 −μ
⎞
⎟⎟⎟⎟⎟⎟⎠
,
where
J1,1 = μ(v + μ)
3 − α(−pv + v + μ)ω(v + μ) − (μ(μ − 2α) + v(2(p − 1)α + μ))ω2
((p − 1)v − μ)(v + μ)ω ,
has characteristic polynomial
p(x) = (x + μ + σ)(a0x3 + a1x2 + a2x + a3),
where
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a1 = (−pv + v + μ)ω
(
(−v − μ)((α − 2μ)μ + v(−pα + α + (p − 2)μ))
− (μ(μ − 2α) + v(2(p − 1)α + μ))ω),
a2 = − μ
(
p2
(
(v + μ)3 − (v − α + μ)ω(v + μ) − 2αω2)v2
+ p(v + μ)(−v(v + μ)2 − 3αω(v + μ) + (v + 5α)ω2)v
+ (v + μ)2(μ(v + μ)2 + (v + 2α − 3μ)ω(v + μ) − (v + 3α − 2μ)ω2))
and
a3 = (pv−v−μ)μ(v+μ)(v+μ−ω)
(
μ(v+μ)2 − (μ(μ−α)+v((p−1)α+μ))ω).
By the Routh–Hurwitz theorem, E∗ will be stable if and only if a1 > 0, a2 > 0, a3 > 0, and
a1a2 − a0a3 > 0.
As function of μ and ω, E∗ exists when X∗ > 0 and ω > v + μ, the region below the graph
of ω(μ) = μ(v+μ)2
μ(μ−α)+v((p−1)α+μ) (the black plot in Fig. 1) and above the graph of ω = v + μ (the
gray plot in Fig. 1). Note that the minimum value of ω(μ) occurs at
λ∗ = 13
(
−v + 2α + v
2 + (5 − 9p)αv + 4α2
3
√
−v3 + 6αv2 − 3(9p − 5)α2v + 8α3 + 3√3√V
+ 3√W
)
,
where
V = (p − 1)v2α(v3 + (3 − 9p)αv2 + 3(1 − 3p)2α2v + (1 − 9p)α3)
and
Fig. 1. E∗ exists for μ and ω values in the shaded region.
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+ 3√3
√
(p − 1)v2α(v3 + (3 − 9p)αv2 + 3(1 − 3p)2α2v + (1 − 9p)α3).
Let T (t) = X(t) + Y(t) + A(t) + Z(t). Assuming E∗ exists, the limit of the total population
size is
T (E∗)(p) = X(E∗) + Y(E∗) + A(E∗) + Z(E∗)
= (μ(v + μ)
2 − (μ(μ − α) + v((p − 1)α + μ))ω)
μ(v + μ)2(−pv + v + μ)2(μ + σ)
× ((v + μ)(μ + σ)ω − pv(μ(v + μ) + σω))
μ(v + μ)2(−pv + v + μ)2(μ + σ) . (5)
Evaluated at p = 1,
T (E∗)(1) = ((v + μ)
2 − (v − α + μ)ω)((v + μ + σ)ω − v(v + μ))
μ(v + μ)2(μ + σ) . (6)
Interestingly, the presence of a reservoir host could enhance the total population size. In Fig. 2,
E∗ exists in the shaded region. In the darker region, E∗(p) > E∗(1) for 0 < p < 1 while in the
lighter region E∗(p) < E∗(1). The figure shows that when growth rates are sufficiently small,
immunity has a negative effect on total population size. The effects of death rates and immunity
on total population size are illustrated in Fig. 3 using the parameter values shown in Table 1.
In column 1 of Fig. 3 we set p = 0.6 (40 percent immune) while in column 2, we set p = 1
(0 percent immune).
Fig. 2. E∗(p), 0 < p < 1, is greater than E∗(1) in the darker shaded region.
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Table 1
Parameter values used for plots in Fig. 3 and total population sizes, T (E∗)(0.6) and T (E∗)(1)
Figures α μ ω v σ T (E∗)(0.6), T (E∗)(1)
(a), (b), (c) 1 0.225 4 0.05625 0.1125 743, 767
(d), (e), (f) 1 0.375 4 0.09375 0.1875 131, 131
(g), (h), (i) 1 1.075 4 0.26875 0.5375 1.65, 0.986
3. The AIDS model for a one locus two allele population
The time of progression from HIV infection to the development of AIDS depends on many
factors. About 5% of the individuals with HIV-1 do not develop AIDS within 10 years of in-
fection. On the other hand, another segment of the individuals infected with HIV develop AIDS
quickly, within 2 to 5 years. As stated above, resistance to the development of AIDS has been
linked to the CCR532 polymorphism. Thus, our model assumes that the progression of HIV
infection to AIDS is genetically linked.
3.1. One locus two allele exponential and logistic growth models
We now consider random mating in a population with three genotypes corresponding to a one
locus, two allele problem. Since we are interested in both ecological and genetic considerations,
we use the continuous time models developed in the works of Nagylaki and Crow, [18], and
Nagylaki, [17], which have been investigated in an ecological context in Freedman and Walt-
man, [11], Butler et al., [9], So and Freedman, [25], So, [26], and Waltman et al., [29], and in
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mathematical models of population genetics.
In a one locus two allele model it is conventional to label the genotypes as AA, Aa, and aa.
Let N = N(t) = N1 +N2 +N3, where N1 is of type AA, N2 is of type Aa, and N3 is of type aa,
denote the population density at time t . The proportion of gametes of each type A and a are given
by
p = 1
N
(
N1 + 12N2
)
and q = 1
N
(
N3 + 12N2
)
, (7)
respectively. Assuming random mating so that the Hardy–Weinberg equation applies, (p+q)2 =
p2 + 2pq + q2 = 1, the continuous time version for the growth of such a population with growth
rate α is
N ′1 = αNp2, N ′2 = 2αNpq, and N ′3 = αNq2. (8)
Fitness can be introduced into the model by choosing a different value of α for each equation,
αi corresponding to Ni and has the form
N ′1 = α1Np2, N ′2 = 2α2Npq, and N ′3 = α3Nq2. (9)
The logistic formulation of the evolution of the genotypes takes the form
N ′1 = αNp2 − μNN1, N ′2 = 2αN − μNN2, and N ′3 = αN − μNN3, (10)
where α/μ is called the carrying capacity and reflects the level to which the population can
grow. Fitness can be introduced into the model by choosing different values of α and μ for each
equation, αi and μi , corresponding to Ni and has the form
N ′1 = α1N − μ3NN1, N ′2 = 2α2N − μ3NN2, and N ′3 = α3N − μ3NN3. (11)
3.2. A one locus two allele AIDS model
For a one locus two allele AIDS model, we use the notation N = N1 + N2 + N3, where
N1 = X1 + Y1 + Z1 is of type AA, N2 = X2 + Y2 + Z2 of type Aa, and N3 = X3 + Y3 + Z3 is
of type aa, where the variables X, Y , A, and Z are defined in system (4). The constants p and
q are given by (7). The density of the susceptible group is X = X1 + X2 + X3, the density of
the infected group is Y = Y1 + Y2 + Y3, the density of the AIDS group is A = A1 + A2 + A3,
and the density of the carriers who do not develop AIDS is Z = Z1 +Z2 +Z3. Using system (4)
as a guide and following the same approach used by Beck et al., [6], and Abell et al., [1], the X
equations for system (4) are
dX1
dt
= α1Np2 − μ1XX1 − ω1 Y
N
X1,
dX2
dt
= 2α2Npq − μ2XX2 − ω2 Y
N
X2,
dX3
dt
= α3Nq2 − μ3XX3 − ω3 Y
N
X3, (12)
the Y equations are
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dt
= ω1 Y
N
X1 − (v1 + μ1)Y1,
dY2
dt
= ω2 Y
N
X2 − (v2 + μ2)Y2,
dY3
dt
= ω3 Y
N
X3 − (v3 + μ3)Y3, (13)
the A equations are
dA1
dt
= p1v1Y1 − (σ1 + μ1)A1,
dA2
dt
= p2v2Y2 − (σ2 + μ2)A2,
dA3
dt
= p3v3Y3 − (σ3 + μ3)A3, (14)
and the Z equations are
dZ1
dt
= (1 − p1)v1Y1 − μ1Z1,
dZ2
dt
= (1 − p2)v2Y2 − μ2Z2,
dZ3
dt
= (1 − p3)v3Y3 − μ3Z3. (15)
We require that the system add back to the original when the relevant parameters are equal
so note that if αi = α, μi = μ, ωi = ω, vi = v, μi = μ, pi = p, and σi = σ , adding equations
(12)–(15) results in system (4).
Immunity and resistance can take several forms.
(1) One genotype may be resistant to acquiring HIV.
(2) One genotype may be resistant to developing AIDS.
Of course, immunity may have costs such as lower growth rates. Some genotypes may be
better transmitters of HIV; some genotypes might be more susceptible.
We now consider several examples that illustrate a few of the situations that might occur. In
the following plots, the density of the AA genotype is plotted in black, Aa is dashed, and aa is in
gray. In all subsequent plots, the initial conditions are X1(0) = 0.15, X2(0) = 0.5, X3(0) = 0.25,
Y2(0) = 0.25 and the remaining initial conditions are 0.
3.3. Homozygote superiority
Homozygote superiority occurs if one of the homozygotes is either resistant to acquiring HIV
or resistant to developing AIDS. Assuming the AA homozygote has superiority, resistance to
acquiring HIV would occur if ω1 < ω2,3. This situation is illustrated in Fig. 4 using the parameter
values given in Table 2.
In this case, we see that the A allele goes to fixation. However, the dominant allele need not
always go to fixation as illustrated in Fig. 5 using the parameter values in Table 3. Figure 5(B)
illustrates that if the resistance has a “cost,” which in this case corresponds to a lower growth rate
(α1 = 0.9), the incidence of infection and AIDS cases can increase.
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Table 2
Parameter values used for plots in Fig. 4
i αi μi ωi vi σi pi
1 1 1 0 0.5 1 0.9
2 1 1 100 0.5 1 0.9
3 1 1 100 0.5 1 0.9
Fig. 5. In (A), α1 = 1 and polymorphism results and AIDS is eliminated from the population. On the other hand, if there
is a “cost” for immunity, which in the case of (B) is a lower growth rate, polymorphism results and AIDS persists in the
population.
Table 3
Parameter values used for plots in Fig. 5
i αi μi ωi vi σi pi
1 1, 0.9 1 0 0.5 1 0.9
2 1 1 3 0.5 1 0.9
3 1 1 3 0.5 1 0.9
If the homozygote can contract HIV, but is more resistant to developing AIDS that the others,
the correspondence is smaller v1, σ1 or p1 values. Figure 6 shows the results using the the para-
meter values given in Table 4. As before, we see that if the resistance has a “cost,” the incidence
of infection increases.
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is a “cost” for immunity, which in the case of (B) is a lower growth rate (α1 = 0.9), polymorphism results and AIDS
persists in the population. In this case, the a allele dominates; the results are highly dependent on the initial conditions.
Table 4
Parameter values used for plots in Fig. 6
i αi μi ωi vi σi pi
1 1, 0.9 1 3 0.5 1 0
2 1 1 3 0.5 1 0.9
3 1 1 3 0.5 1 0.9
Fig. 7. Polymorphism results in both cases, although the initial conditions can give one homozygote an advantage over
the other.
Table 5
Parameter values used for plots in Fig. 7
i αi μi ωi vi σi pi
1 1 1 3 0.15 1 0.6
2 1, 0.9 1 0 0.15 1 0.6
3 1 1 3 0.15 1 0.6
3.4. Heterozygote superiority
Heterozygote superiority occurs if the heterozygote is either resistant to acquiring HIV or
resistant to developing AIDS. In this situation, polymorphism typically occurs. Figure 7 illus-
trates the situation using the parameter values given in Table 5. As with homozygote superiority,
a “cost” associated with the resistance (that is, a reduction in the growth rate) leads to increases
in the incidence of the disease.
20 M. Abell et al. / J. Math. Anal. Appl. 333 (2007) 8–23Fig. 8. Depending upon the initial conditions, the lower growth rate of the heterozygote can cause one allele to go to
fixation.
Table 6
Parameter values used for plots in Fig. 8
i αi μi ωi vi σi pi
1 1 1 3 0.15 1 0.6
2 1, 0.9 1 3 0.15 1 0
3 1 1 3 0.15 1 0.6
Fig. 9. In the limit as t → ∞, the allele frequencies are constant although the ratio depends on the initial conditions.
However, the initial conditions can affect the outcome and one allele can go to fixation as
illustrated in Fig. 8 using the parameter values given in Table 6. In this case, the heterozygote is
resistant to developing AIDS once infected with HIV but the “cost” of the immunity corresponds
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Parameter values used for plots in Fig. 9
i αi μi ωi vi σi pi
1 1, 0.9, 1, 0.9 1 0, 0, 3, 3 0.15 1 0.6, 0.6, 0, 0
2 1, 0.9, 1, 0.9 1 3, 3, 0, 0 0.15 1 0, 0, 0.6, 0.6
3 1 1 3 0.15 1 0.6
to a slightly lower growth rate than that for the homozygotes. However, the lower growth rate
does not lead to increases in the incidence of the disease in all cases as it did in Fig. 7. In this
case, the a allele goes to fixation.
Of course, many other combinations can be considered as illustrated in Fig. 9 using the para-
meter values in Table 7.
The lower growth rate in (B) results in a reduction in domination by X1 over X2 and X3 in
that X1 decreases while X2 increases. In (D), the reduction in the growth rate causes X2, Y2, A2,
and Z2 to increase dramatically over the corresponding values in (C).
4. Conclusion
In this paper we have introduced basic genetics into an AIDS model. From an ecological per-
spective, the important quantity is the size of the evolving genotypic sub-populations while from
a genetic perspective the important quantity is the relative proportion of the alleles. To incor-
porate both of these considerations, we began with a basic growth model based on the logistic
equation and then incorporated the relationship between three genotypes into the system of dif-
ferential equations typically used to model this situation. We considered the situations in which
a homozygote or the heterozygote has an advantage over the other genotypes in its immunity
or resistance to a disease like AIDS. Generally, if a homozygote has an advantage, we see that
one allele eliminates the other. On the other hand, if the heterozygote has an advantage, poly-
morphism results even if one of the homozygotes is subjected to disadvantages. Generally, if one
allele gives an advantage over another, its frequency increases. This paper does not take epistasis
into account, which may also be very important in the development of AIDS in HIV infected
individuals, nor does it take into account the interactions that occur between infection with HIV
and other infections, like TB (see Naresh and Tripathi, [19]).
We illustrate that combining genetic and ecological models allows us to examine population
sizes and densities as well as genotypic and phenotypic frequencies so it is of interest to ecolo-
gists, geneticists, and mathematicians.
5. Computational remarks
Mathematica code that numerically solves system (12)–(15) and generates the figures in this
paper is available from the authors by sending a request to Jim Braselton at jbraselton@
georgiasouthern.edu.
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